Morphologic aspects of rodent cardiotoxicity in a retrospective evaluation of National Toxicology Program studies. 2011

Micheal P Jokinen, and Warren G Lieuallen, and Michael C Boyle, and Crystal L Johnson, and David E Malarkey, and Abraham Nyska
Charles River Laboratories-Pathology Associates, Durham, North Carolina, USA.

The heart is increasingly recognized as a target for toxicity. As studies in laboratory rodents are commonly used to investigate the potential toxicity of various agents, the identification and characterization of lesions of cardiotoxicity is of utmost importance. Although morphologic criteria have been established for degenerative myocardial lesions in rats and mice, differentiation of spontaneously occurring lesions from toxin-induced or toxin-related lesions remains difficult. A retrospective light microscopic evaluation was performed on the hearts of F344 rats and B6C3F(1) mice from National Toxicology Program (NTP) studies of six chemicals identified in the NTP database in which treatment-induced myocardial toxicity was present. Two previously defined myocardial lesions were observed: "cardiomyopathy" that occurred spontaneously or as a treatment-related effect and "myocardial degeneration" that occurred as a treatment-related effect. Both lesions consisted of the same basic elements, beginning with myofiber degeneration and necrosis, with varying amounts of inflammation, interstitial cell proliferation, and eventual fibrosis. This observation is indicative of the heart's limited repertoire of responses to myocardial injury, regardless of the nature of the inciting agent. A prominent differentiating factor between spontaneous and treatment-induced lesions was distribution and lesion onset. Once the respective lesions had undergone fibrosis, however, they generally appeared morphologically indistinguishable.

UI MeSH Term Description Entries
D008853 Microscopy The use of instrumentation and techniques for visualizing material and details that cannot be seen by the unaided eye. It is usually done by enlarging images, transmitted by light or electron beams, with optical or magnetic lenses that magnify the entire image field. With scanning microscopy, images are generated by collecting output from the specimen in a point-by-point fashion, on a magnified scale, as it is scanned by a narrow beam of light or electrons, a laser, a conductive probe, or a topographical probe. Compound Microscopy,Hand-Held Microscopy,Light Microscopy,Optical Microscopy,Simple Microscopy,Hand Held Microscopy,Microscopy, Compound,Microscopy, Hand-Held,Microscopy, Light,Microscopy, Optical,Microscopy, Simple
D009202 Cardiomyopathies A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). Myocardial Disease,Myocardial Diseases,Myocardial Diseases, Primary,Myocardial Diseases, Secondary,Myocardiopathies,Primary Myocardial Disease,Cardiomyopathies, Primary,Cardiomyopathies, Secondary,Primary Myocardial Diseases,Secondary Myocardial Diseases,Cardiomyopathy,Cardiomyopathy, Primary,Cardiomyopathy, Secondary,Disease, Myocardial,Disease, Primary Myocardial,Disease, Secondary Myocardial,Diseases, Myocardial,Diseases, Primary Myocardial,Diseases, Secondary Myocardial,Myocardial Disease, Primary,Myocardial Disease, Secondary,Myocardiopathy,Primary Cardiomyopathies,Primary Cardiomyopathy,Secondary Cardiomyopathies,Secondary Cardiomyopathy,Secondary Myocardial Disease
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010110 Oxymetholone A synthetic hormone with anabolic and androgenic properties. It is used mainly in the treatment of anemias. According to the Fourth Annual Report on Carcinogens (NTP 85-002), this compound may reasonably be anticipated to be a carcinogen. (From Merck Index, 11th ed) Hydroxymetholone,Anadrol,Anapolon 50,Oxymethalone,Oxymetholone, (17 beta)-Isomer,Oxymetholone, (5 alpha,17 alpha)-Isomer
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D006078 Government Programs Programs and activities sponsored or administered by local, state, or national governments. Government-Sponsored Programs,Government Sponsored Programs,Government Program,Government Sponsored Program,Government-Sponsored Program,Program, Government,Program, Government Sponsored,Program, Government-Sponsored,Programs, Government,Programs, Government Sponsored,Programs, Government-Sponsored
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006651 Histocytochemistry Study of intracellular distribution of chemicals, reaction sites, enzymes, etc., by means of staining reactions, radioactive isotope uptake, selective metal distribution in electron microscopy, or other methods. Cytochemistry
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

Micheal P Jokinen, and Warren G Lieuallen, and Michael C Boyle, and Crystal L Johnson, and David E Malarkey, and Abraham Nyska
April 2011, Toxicologic pathology,
Micheal P Jokinen, and Warren G Lieuallen, and Michael C Boyle, and Crystal L Johnson, and David E Malarkey, and Abraham Nyska
August 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology,
Micheal P Jokinen, and Warren G Lieuallen, and Michael C Boyle, and Crystal L Johnson, and David E Malarkey, and Abraham Nyska
February 1996, Mutation research,
Micheal P Jokinen, and Warren G Lieuallen, and Michael C Boyle, and Crystal L Johnson, and David E Malarkey, and Abraham Nyska
November 1985, Environmental health perspectives,
Micheal P Jokinen, and Warren G Lieuallen, and Michael C Boyle, and Crystal L Johnson, and David E Malarkey, and Abraham Nyska
December 2002, Annals of the New York Academy of Sciences,
Micheal P Jokinen, and Warren G Lieuallen, and Michael C Boyle, and Crystal L Johnson, and David E Malarkey, and Abraham Nyska
January 2002, Toxicologic pathology,
Micheal P Jokinen, and Warren G Lieuallen, and Michael C Boyle, and Crystal L Johnson, and David E Malarkey, and Abraham Nyska
February 1981, Teratology,
Micheal P Jokinen, and Warren G Lieuallen, and Michael C Boyle, and Crystal L Johnson, and David E Malarkey, and Abraham Nyska
January 1984, Progress in clinical and biological research,
Micheal P Jokinen, and Warren G Lieuallen, and Michael C Boyle, and Crystal L Johnson, and David E Malarkey, and Abraham Nyska
October 2012, Regulatory toxicology and pharmacology : RTP,
Micheal P Jokinen, and Warren G Lieuallen, and Michael C Boyle, and Crystal L Johnson, and David E Malarkey, and Abraham Nyska
March 1982, Pharmacological reviews,
Copied contents to your clipboard!